irAEs Associated With Prolonged PFS and OS in NSCLC

A retrospective study suggested that irAEs with second-line nivolumab are associated with PFS and OS in patients with advanced NSCLC.

from Latest articles from Cancer Therapy Advisor News https://ift.tt/2OSq92b